A public-private partnership created the Program.
Introduction: Targeting Non-communicable Diseases in Low-and Middle-

Income Countries
Between 1990 and 2010 the global non-communicable diseases (NCDs) burden increased from 43% to 54% of the total disease burden. 1 In 2012, globally, almost three quarters (74%) of all the NCD burden occurred in low-and middle-income countries. 2 Population growth and population aging have contributed substantially to the expanding NCD burden trendsboth of which are rapidly occurring within low and middle income country populations. 3, 4 Effectively tackling this growing NCD burden in low-and middle-income country settings presents a major challenge, yet, is an achievable task. 2, 3, 5 Today, many effective NCD interventions are available. The World Economic Forum and World Health Organization (WHO) recently developed a report targeted at decision makers, civil society, and the private sector, that provides assessments of the economic impact of noncommunicable diseases and costs of scaling up a core of proven-effective interventions within low-and middle income counties. 6 However, responding to these challenges in lowand middle-income countries will need local research capacity building, 7 so that interventions are driven by in-country knowledge-bases provided through research performed in low-and middle-income countries. Yet, research infrastructure and outputs in low and middle income countries are woefully inadequate, and the data from these settings are scarce. 3, 8 This situation poses problems both for implementation of known interventions and also for tackling low-and middle-income country disease patterns, phenotypes that might differ from high-income countries.
To address research needs for NCDs in low-and middle-income countries, in 2009, the National Heart, Lung, and Blood Institute (NHLBI) and UnitedHealth Group (UHG) engaged in a Chronic Disease Initiative (2009-2014), previously described, 9, 10 which supported a network of eleven low-and middle-income country-based research centers -six of which were supported by both institutions -based in ten countries. (Figure 1 ) This publicprivate partnership created the NHLBI-UnitedHealth Global Health Centers of Excellence (COE) Program (referred to hereafter as the Program). The Program's overall goal was to contribute to the reduction of cardiovascular and lung disease burdens by catalyzing incountry research institutions to develop a global network of biomedical research centers that conduct collaborative research, train researchers, and advise on policy. Our purpose here is to describe an overview of achievements and lessons learned from the eleven COEs supported by the Program, based in Argentina, Bangladesh, China, Guatemala, India (2 centers), Kenya, Mexico, Peru, South Africa and Tunisia. A formal evaluation of the Program is underway and is planned for completion in 2016. a U.S. based administrative coordinating center (Westat) provided administrative, logistical, and data management support, and coordination of key activities (e.g., site establishment, institutional review board coordination and tracking, and protocol registration). Finally, each COE partnered with at least one developed (high-income) country academic institution based in the United States, Canada, Europe, or Australia and with local partner organizations such as health care institutions, universities and research institutions, non-governmental agencies, and government bodies. Developed country partners provided technical and research support to facilitate growth of each center's research capacity and capability.
This initiative built on best practices of collaborative scientific work, yet was far more innovative in terms of capacity building and empowerment, both scientifically and administratively. The Program was designed so that the low-and middle-income country applicants were the prime recipient of the award. Many of the COEs had to quickly mature scientifically and bring their administrative and grant management procedures to international standards. In so doing, the COE platform lifted not only the scientific potential of partners, but their ability to improve financial, managerial, legal and accounting procedures. These major in-country gains proactively countered the pervasive model of "parachuting" research -all too common within international collaborations.
Developing Research Platforms: Collaboration Based Approach
Each COE developed its research platform, collaboration network, and priority research areas for heart and lung diseases. The characteristics of each COE and its developed country partner and local partner institutions varied, resulting in each platform having unique features. The research focused on disease epidemiology, prevention and control along with training future investigators (e.g., graduate, postdoctoral).
Program governance was led by a Steering Committee which included NHLBI, UHG and Westat leadership and both COE and develop country partner principal investigators. It provided: scientific oversight and advice on network activities; facilitated collaboration across COEs to ensure that mechanisms and strategies led to achieving program goals; advice on partnerships and global health opportunities; a venue for sharing research accomplishments, as well as generating common policies, guidelines, and procedures for the network. NIH best practices and guidelines for research, training, ethics, and data policies and procedures were adopted Program-wide. Working subcommittees of the Steering Committee were composed of investigators and staff from the COEs, developed country partners, NHLBI, UGH, and Westat. Subcommittees were created for training, epidemiology, pulmonary diseases, and community health workers.
A total of 38 original research activities were conducted between 2009 and 2014. (Table 1) Three study approaches were employed: single COE led studies that were driven by unique local needs and opportunities conducted in one (25 studies) or multiple sites (7 studies) within a center and multi-COEs studies harmonized across centers addressing a common health priority issue (6 studies). The type of study designs included epidemiological (43%), behavioral (21%), interventional (17%), and other types (19% encompassing health economics, model development, and feasibility studies). ( research studies conducted by each COE ranged from two (Argentina, India-New Delhi, Mexico, and Tunisia) to seven (Guatemala). These original studies yielded a substantial number of publications (peer-reviewed scientific journals, reports, press releases, and news articles), presentations, media coverage, and involvement of COE trainees in research efforts. (Table 2) The program provided network-wide interactions (four structured exchanges each year, two being face to face) and flexibility that promoted creativity, cooperation and enhanced training. Additional supplemental funding provided resources to support strategic collaborative studies and by year two of the Program, the dynamics of the group transformed from being a group of funded institutions conducting their own research into a network of colleagues working together in synchrony where the whole was much greater than the sum of its parts.
Research Training: High Priority Pipeline for Future Investigators
A key component of the Program was training future researchers. The objectives of the training efforts were to: i) develop staff capable of conducting independent and/or collaborative research, ii) train future cardiovascular and pulmonary investigators at the doctoral and postdoctoral levels; and iii) stimulate clinical, epidemiologic, health services, health policy, and behavioral research. Each institution developed training plans that responded to skill gaps within their country settings. Some training opportunities were the result of single COE efforts while others involved collaboration with developed country partners, other COEs, and local partners. While training activities within individual COEs were tailored to meet local needs, there were several common elements employed throughout the Program. The breadth and depth of the training component were evident across the entire Program and reflected the high level of commitment to this objective as described in this issue of the Journal. 11
High Level Collaboration: Development of a Program Wide Harmonized
Data Commons
During the active research phase of the Program, several collaborations received supplemental funding to address common priority topics across COEs including, but not limited to, community health workers, 12, 13 clean cookstoves, 14 and NCD risk stratification and management. 15, 16 . Others took advantage of the well characterized cohorts to ask fundamental basic science questions such as a comparative analysis of the pulmonary microbiome within biomass fuel exposed and unexposed populations.
A network-wide collaboration allowed the Program to develop a data commons of harmonized variables across several COE studies. This approach provided opportunities to maximize use of established datasets and increase the impact of the work supported by the Program. This aligned well with NHLBI's call for more innovative uses of data across all research investments. [17] [18] [19] and Engelgau Page 4
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Forty data collection instruments from 14 primary research studies were reviewed to identify common variables anticipated as valuable for multiple site analyses. Not all variables were available within each research activity, and specific criteria and methodology were created for multisite analyses. A master codebook was developed and data files were shared for planned analyses.
Data harmonization required expert knowledge of the research, database structure, data management, programming, researcher commitment, and consensus on standardized variables. Many of these challenges are common to meta-analysis and other data pooling efforts. 20, 21 Some of the key lessons during this process included: anticipating and planning common studies across sites upfront; using common protocols and data collection instruments with standardized variables across sites when possible (e.g., Clinical Data Interchange Standards Consortium 20 ); employing data management best practices at all sites to minimize errors in data submitted for harmonization; and, allowing time and resources during the lifetime of the Program for talent exchange and targeted resource support to foster high quality outputs and collaboration between groups.
Yet, in spite of all these challenges, a harmonized data commons provided many opportunities. Additional research questions -those not answerable solely from the individual site data -now can be tackled in more depth and breath. Some advantages to this approach include: the ability to make unique global comparisons across countries and continents and assess common issues in highly varied contexts in much more depth than other global studies, 1 better precision for estimates with larger samples that allow more detailed analyses; and finally, promoting greater collaboration and efficiencies in future research efforts. To date, this global harmonized data commons has led to at least 5 studies, including some featured in this issue of the Journal that offer insight into cardiovascular disease, [22] [23] [24] diabetes, 25 and obesity. 26 In addition to this harmonized data commons, all Program data have been submitted to the NIH for compilation, consistent with the agency's policy. 27, 28 Data sets were de-identified and redaction plans were developed for creation of public use datasets. In September, 2016, datasets are planned to be made available in the public domain via NHLBI's data repository, BioLINCC
Discussion
This Program embraced a strategic approach for tackling non-communicable diseases in lowand middle-income countries. With the growing burden of non-communicable diseases in this setting and a knowledge base of effective interventions available, the need to gain locally-driven research efforts that can identify and address priority health issues in specific country settings is essential.
The Program built both research and administrative capacity while training the next generation of U.S. and low-and middle-income country-based researchers. For example, the Program pioneered capacity development for conducting NCD surveillance, which at the country level remains a major weakness. In addition, Program efforts created an instrument for assessing county-level capability to respond to NCDs. 29, 30 COEs have also catapulted development of innovative interventions and their implementation-much needed in both low-and middle-income countries. 15 Supplementary grants promoted cross-collaboration between COEs and resulted in fast-track development and testing of state-of-the-art interventions combining technology with implementation in real-world settings. An example is technology-driven CVD risk ascertainment by community health workers in India and China. 16 The U.S. Council on Foreign Relation's call to engage in global health is driven by the fact that the burden of death and disability is heavily NCD-related within many low and middleincome countries, and because non-communicable diseases are undermining the effectiveness of existing U.S. global health investments. 27 This has led to their call for the U.S. government to build on existing U.S. global health platforms that can achieve sustainable reductions in premature death and disability that disproportionately affect the poor.
A unique component of this Program is that it was led by institution and investigators in lowand middle-income countries. The investigators developed and executed the research programs engaging local and global partners, ultimately creating a south to-south driven research collaborative network unique within the world. This organizational structure fostered in-country capacity development and training components. Both capacity and training are essential in assuring that a sound research platform and a skilled research workforce is produced. Through providing context specific evidence, this Program will guide future research and disease prevention and control efforts. The funding structure of the program allowed for very frequent direct interactions between funding institutions (NHLBI, UHG) and the COEs. This also resulted in a benefit to the funders, as they were able to appreciate and fully understand the challenges faced by researchers in low-and middleincome countries, and therefore strengthen instructional capacity for future funding of research conducted in these settings.
Another key element this Program embraced was collaborations-multiple partners and bidirectional, diverse collaborations-across all levels. This is very consistent with recent calls for more team science, which has been shown to be impactful, foster innovation and productivity, and obtain more broad reach and uptake. [31] [32] [33] Even at the Program's genesis, the innovative public-private partnership between NHLBI and UHG led the way. The collaborative network that subsequently developed had three key dimensions. First, the lowand middle-income country researchers joined with developed country partners. Second, peer to peer collaboration and learning across the Program network between in-country researchers-those who experienced very similar challenges-was invaluable for sharing lessons learned while working across highly diverse environments. Finally, development of a data commons and harmonizing data for multisite analyses represents one of the highest levels of collaboration, where skills, resources, and data are shared-resulting in highly unique analyses and outputs. In addition, other partners joined the network. The U.S. Centers for Disease Control and Prevention (CDC), the American Thoracic Society, and Medtronic Foundation capitalized on the network structure and contributed financially and technically to the Program. While many challenges arose and lessons were learned during 35 Finally, much of the initial work for the creation of a cardiac care unit and division in Kenya was facilitated by the energy and attention that the Kenya NHLBI COE program fostered. 36 Beyond this global Program, NHLBI is engaged in many other areas 37 including the Global Alliance for Chronic Disease, 38 
Conclusions
As the Institute of Medicine recently affirmed, reducing the burden of cardiovascular and other chronic diseases worldwide -especially in low-and middle-income countries -is an achievable goal. 5 Tackling this challenge and achieving the Global Sustainable Development Goals for 2016 to 2030 44 will require innovative strategies that invest in country-based research capacity development, create global networks of researchers, and expand collaboration between the U.S. and low-and middle-income countries. Such efforts can lead to scaling-up of the National Economic Forum's and World Health Organization's "best buys" -effective, affordable interventions for specific real world settings guided by countrydriven health priorities. 5, 45, 46 The GRAND South Network and it successes clearly illustrates that it can be done.
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